Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HALFMOON TomoTherapy (Helical ALtered Fractionation for iMplant partial OmissiON): implant-sparing post-mastectomy radiotherapy reshaping the clinical target volume in the reconstructed breast.
Leonardi MC, Spoto R, Miglietta E, Trivellato S, La Rocca E, Luraschi R, Grosso P, De Lorenzi F, Fodor C, Dicuonzo S, Dell'Acqua V, Gerardi MA, Morra A, Francia CM, Rietjens M, Galimberti VE, Veronesi P, Orecchia R, Cattani F, Jereczek-Fossa BA. Leonardi MC, et al. Among authors: galimberti ve. J Cancer Res Clin Oncol. 2019 Jul;145(7):1887-1896. doi: 10.1007/s00432-019-02938-8. Epub 2019 May 29. J Cancer Res Clin Oncol. 2019. PMID: 31144158
Mondor's disease and breast cancer.
Catania S, Zurrida S, Veronesi P, Galimberti V, Bono A, Pluchinotta A. Catania S, et al. Cancer. 1992 May 1;69(9):2267-70. doi: 10.1002/1097-0142(19920501)69:9<2267::aid-cncr2820690910>3.0.co;2-u. Cancer. 1992. PMID: 1562972 Free article.
Prediction of response to primary chemotherapy for operable breast cancer.
Colleoni M, Orvieto E, Nolé F, Orlando L, Minchella I, Viale G, Peruzzotti G, Robertson C, Noberasco C, Galimberti V, Sacchini V, Veronesi P, Zurrida S, Orecchia R, Goldhirsch A. Colleoni M, et al. Eur J Cancer. 1999 Apr;35(4):574-9. doi: 10.1016/s0959-8049(99)00005-2. Eur J Cancer. 1999. PMID: 10492630
Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN).
Nolè F, Minchella I, Colleoni M, Orvieto E, Munzone E, de Braud F, Peruzzotti G, Martinelli G, Zampino MG, Catania C, Pizzamiglio M, Veronesi P, Zurrida S, Galimberti V, Goldhirsch A, Veronesi U. Nolè F, et al. Ann Oncol. 1999 Aug;10(8):993-6. doi: 10.1023/a:1008389106575. Ann Oncol. 1999. PMID: 10509165 Free article. Clinical Trial.
301 results